SpyGlass Pharma, Inc. (SGP)
Last updated: 2026-10-21 16:10:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
SpyGlass Pharma, Inc. (SGP) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $26.87, with a market capitalization of $822.82M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $17.06 to $32.44. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$822.82M | |
$26.52 | |
$35.15 | |
$11.97 | |
$26.16 | |
36.36K | |
99.72K | |
-- | |
$32.44 | |
$17.06 | |
-- | |
-- |
SpyGlass Pharma, Inc. (SGP) Stock Price Today
SpyGlass Pharma, Inc. (SGP) is currently trading at $26.87 as of 2026-10-21 16:09:00, up 2.71% ($0.71) from the previous close of $26.16
During today's regular trading session, SGP has traded between $11.97 and $35.15, with a trading volume of 36.36K shares. The current price is near the middle of today's range.
SpyGlass Pharma, Inc. (SGP) 7-Day Stock Price Change
Over the past seven days, SpyGlass Pharma, Inc. (SGP) moved from $24.86 to $26.87, representing a gain of 8.09% ($2.01).
The stock traded between $22.80 and $27.22 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 65.62 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
SGP 52-Week Price Position
Position in Range: 63.8%
SGP is currently trading at $26.87, placing it 63.8% of the way from its 52-week low of $17.06 to its 52-week high of $32.44. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is SpyGlass Pharma, Inc. (SGP)?
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.
SpyGlass Pharma, Inc. Information
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 65 |
| Exchange | NASDAQ |
| Company Website |
How to Buy SpyGlass Pharma, Inc. (SGP) Stock on MEXC
Eligible investors can buy real shares of SpyGlass Pharma, Inc. (SGP) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is SpyGlass Pharma, Inc. (SGP) stock price today?
2.Is SGP stock going up or down today?
3.What is SGP pre-market price?
4.What is SGP after-hours price?
5.Is SGP stock trading now?
6.Where does SGP sit relative to its 52-week high and low?
7.What sector is SpyGlass Pharma, Inc. in?
8.What is SpyGlass Pharma, Inc.'s market capitalization and where is it listed?
9.How is SGP valued in terms of P/E ratio and EPS?
10.Does SpyGlass Pharma, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
SGP Stock Calculator
Estimate the value between SGP shares and USD.
SGP Shares to USD
1.00 SGP shares = 26.87 USD
Calculations are estimates based on the latest available price and are for reference only.


